Bryce Allen

Bryce Allen is the Co-Founder & CEO at Differentiated Therapeutics. Previously he was the founding Head of Integrated Data Science at Silicon Therapeutics which was acquired by Roivant Sciences for $450M. In addition Bryce was a Post-doctoral Fellow in the Department of Biomedical Informatics at Harvard Medical School where he developed algorithms to prioritize therapeutic interventions for patient disease trajectories using representation learning and Markov state modeling.